Mycoplasma bacteria are ubiquitous and the smallest known free-living life forms
They reside extracellularly in the respiratory and urogenital tracts (though they can be systemic in case of immunosuppression)
Mycoplasma bacteria do not have cell wall, hence they cannot be detected by Gram-staining. For the same reason, they are not susceptible to beta-lactams.
Their pathology is mainly immune-mediated
Mycoplasma pneumonia (also known as “walking pneumonia” due to its mild form of manifestation) is type of atypical bacterial pneumonia that is caused by Mycoplasma pneumoniae. It is mainly a self-limiting disease (though it can be severe in isolated cases).
It is the most common agent that causes bacterial pneumonia in people who stay close together e.g. family members, students and military officers.
People at the risk of developing mycoplasma pneumonia are elderly, immunosuppressed, people with lung and sickle cell disease.
Statistics: incidence of 2M cases annually in USA (data not available for developing countries); it is responsible for about 20% of pneumonia in a community.
Mild shortness of breath moreso with exertion
In rare cases symptoms of the following diseases can be manifested: arthritis, pericarditis, encephalitis, renal failure, anemia, Guillain-Barré syndrome, Stevens-Johnson syndrome and toxic epidermal necrolysis
Full Blood Count
Foreign body aspiration
##For children and adults;
Levofloxacin or Moxifloxacin or other quinolones
## Corticosteroids therapy
Drug Index 2.0 is hereOur new update features a more powerful search feature and easier login.
issues? Contact us
today. Contact Us